Global Health Ltd (ASX: GLH) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Global Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $7.98 million
P/E Ratio 43.48
Dividend Yield 0.00%
Shares Outstanding 58.05 million
Earnings per share -0.112
Dividend per share N/A
Year To Date Return -4.17%
Earnings Yield 2.30%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Global Health Ltd (ASX: GLH)
    Latest News

    a woman
    ⏸️ Investing

    Global Health Limited grows profit and ramps up research in FY 2014: Should you buy?

    Are Global Health Limited (ASX:GLH) shareholders on to a winner?

    Read more »

    ⏸️ Investing

    3 high-risk stocks I'd buy with $5,000

    Global Health Limited (ASX:GLH), Strike Energy Ltd (ASX:STX) and Australian Bauxite Ltd (ASX:ABX) could be just what you’re looking for.

    Read more »

    a woman
    ⏸️ Investing

    5 speculative microcaps that could thump the market

    Speculative stocks carry considerable risk - but the rewards can be splendiferous...

    Read more »

    a woman
    ⏸️ Investing

    7 speculative stocks deserving your attention

    Sometimes, it pays to give luck a chance...

    Read more »

    ⏸️ Investing

    4 companies that could double in the next 5 years

    Strong earnings growth means these four companies could be about to take off!

    Read more »

    a woman
    ⏸️ Investing

    3 stocks primed for over 10% sustainable EPS growth

    What does Warren Buffett have to say about 'growth investing,' and are these companies undervalued?

    Read more »

    a woman
    ⏸️ Investing

    Do you know these 5 TOP growth stocks?

    Their share prices have taken a beating, providing savvy investors some great buying opportunities.

    Read more »

    a woman
    ⏸️ Investing

    3 stocks that fell last week to buy this week

    A moody market and falling prices make a great time to buy.

    Read more »

    a woman
    ⏸️ Investing

    These 4 small-caps stars could be tomorrow's big successes

    Four of today’s small-caps which could become tomorrow’s blue-chips.

    Read more »

    a woman
    ⏸️ Investing

    This week's top two healthcare buys: ResMed Inc and Global Health Limited

    Two companies with strong prospects for health-consious investors.

    Read more »

    a woman
    ⏸️ Investing

    3 stocks I've got my eye on after ASX plunges

    ASX 200 crashes more than 1%, stocks on sale

    Read more »

    ⏸️ Investing

    5 superstar small-cap stocks

    One of these companies is already up 110%. The year of the small-cap has certainly arrived, have you prepared yourself…

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    01 Mar 2017 $0.0100 0.00% Special 09 Mar 2017
    03 Nov 2016 $0.0100 0.00% Special 25 Nov 2016

    GLH ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Global Health Ltd

    Global Health Ltd is engaged in developing, selling, and supporting application software for the healthcare sector in Australia. It operates in a single segment, being the computer technology, software, and services industry. It provides mental health software for psychologists and psychiatrists; integrated software solutions for various areas of community health and human services, including drug and alcohol, disability, dental, and community rehabilitation; and digital software for healthcare communities.

    GLH Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    21 Nov 2024 $0.14 $0.01 7.69% 4,649 $0.14 $0.14 $0.14
    20 Nov 2024 $0.13 $0.00 0.00% 50 $0.13 $0.13 $0.13
    19 Nov 2024 $0.13 $0.00 0.00% 9,950 $0.13 $0.13 $0.13
    18 Nov 2024 $0.13 $-0.01 -7.14% 9,063 $0.13 $0.13 $0.13
    13 Nov 2024 $0.14 $0.00 0.00% 36,452 $0.14 $0.14 $0.14
    12 Nov 2024 $0.14 $0.00 0.00% 51 $0.14 $0.14 $0.14
    07 Nov 2024 $0.14 $0.00 0.00% 26,683 $0.14 $0.14 $0.14
    28 Oct 2024 $0.15 $-0.01 -6.67% 26,682 $0.15 $0.15 $0.15
    23 Oct 2024 $0.15 $0.00 0.00% 66 $0.15 $0.15 $0.15

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    28 Aug 2024 Steven Pynt Issued 50,000 $50,000
    Issue of securities.
    28 Aug 2024 Alumootil Cherian Issued 50,000 $50,000
    Issue of securities.
    28 Aug 2024 Stuart Smith Issued 50,000 $50,000
    Issue of securities.
    28 Aug 2024 Karen Corry Issued 50,000 $50,000
    Issue of securities.
    28 Aug 2024 Steven Strange Issued 50,000 $50,000
    Issue of securities.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Steven Leigh Pynt Non-Executive ChairmanNon-Executive Director Jan 2000
    Mr Pynt is a Director of the Perth legal firm, MP Commercial Lawyers, and his main area of practice is in commercial law including corporations' law, franchising and contracts. He was formerly a member of the Racing Penalties Appeals Tribunal and Chairman of the Commercial Tribunal of WA.
    Mr Alumootil Mathew Cherian Executive DirectorManaging Director Jan 2000
    Mr Cherian has been in the information technology industry since 1981. In 1985, he established Working Systems Pty Ltd in Perth, Western Australia. Mr Cherian was appointed CEO of Working Systems Solutions Limited in January 2002 to re-focus the Group as a software product developer for the Healthcare sector. The initial phase culminated with the re-branding of the Company as Global Health Limited in December 2007. Mr Cherian plays an active role in product strategy and the development of overseas markets for the Company.
    Mr Stuart Grant Smith Non-Executive Director Sep 2013
    Mr Smith has worked in insurance, superannuation, investment and funds management for over 40 years. He started with National Mutual (now AMP) in the investments division and was responsible for the establishment of the funds management business for National Mutual. In 1984, he established an independent funds management group and floated Hospitals of Australia - the first healthcare investment fund in Australia. Hospitals of Australia owned and operated a number of hospitals throughout Australia. Mr Smith was intimately involved in the building of a number of hospitals including Strathfield Private, Southern Highlands Private Hospital, Port Macquarie Hospital and the refurbishment of a number of other healthcare facilities. Hospitals of Australia was ultimately acquired by Mayne Nickless Limited. In the past 15 years, Mr Smith developed and built the Medica Centre and opened the first digital (paperless) private surgical hospital in Australia. He is currently involved in developing new hospitals in Melbourne. Mr Smith is also involved in utilising digital technology to generate increased productivity and efficiencies for the Healthcare sector.
    Ms Karen Corry Non-Executive Director Aug 2021
    Ms Corry is an experienced board director and business leader with a background in digital health, technology and finance. Previously a partner at KPMG , including KPMG London. In her consulting career she has led strategic planning and major transformational programs and has been responsible for business development and growth. She established a consulting company, Delta Management Consulting, achieving success developing and delivering digital health strategy for over a decade in the public and private health sectors. Karen is a non-executive director at Peninsula Health, Holmesglen Institute, ACMI (Australian Centre for the Moving Image), Chair of the Australian Community Support Organisation (ACSO), and the Cultural Development Network (NFP). She chairs the Audit and Risk committees of Holmesglen and ACMI, and the Digital Health & Capital Projects committee at Peninsula. She is a Fellow of the AICD and in 2020 was privileged to participate in the AICD Chair's Mentoring Program. Her experience leverages strategy and growth with a strong balance between innovation, governance, finance and risk.
    Mr Steven Strange Non-Executive Director Jul 2022
    Mr Strange brings over 30 years of leadership experience to the Board at a very opportune and pivotal time, where the Company seeks to significantly grow its business both domestically and in its positioning in the Asia Pacific Region. Steven was the Founder and Executive Director of Health Metrics (HM) a leading provider of software solutions to the aged care sector. He also recently successfully completed the sale of HM to Private Equity interests
    Mr James Stephen Barrie Company Secretary Jan 2023
    -
    James Stephen Barrie Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Micron Holdings Pty Ltd (Cherian Family A/C) 17,370,324 29.92%
    J P Morgan Nominees Australia Pty Limited 8,490,802 14.63%
    Micron Holdings Pty Ltd (Micron Holdings Super A/C) 5,388,795 9.28%
    Mr Paul McLaren 2,027,745 3.49%
    Sandhurst Trustees Ltd (Collins St Value Fund A/C) 1,801,802 3.10%
    Mrs Elizabeth May Priscilla Thomas 1,728,378 2.98%
    Connaught Consultants (Finance) Pty Ltd (Super Fund A/C) 1,206,236 2.08%
    Alumootil Mathew Cherian 1,017,500 1.75%
    Dr Russell Kay Hancock 1,000,000 1.72%
    Ms Serene Lim & Mr Nicholas Russell Ward (Serene Lim Superfund A/C) 860,000 1.48%
    Triglobal Management Limited 700,000 1.21%
    Emerald Shares Pty Limited (Emerald Unit A/C) 650,000 1.12%
    Mr Brendan Thomas Birthistle 582,861 1.00%
    Dr Serene Lim (Serene Lim Family A/C) 525,000 0.90%
    Chris Bell Investments Pty Ltd (The Chris Bell S/F A/C) 500,000 0.86%
    Dr David Leroy Boyles 500,000 0.86%
    Annex Partners Pty Ltd 500,000 0.86%
    Roxanne Investments Pty Ltd 424,481 0.73%
    Micron Holdings Pty Ltd (Micron Holdings P/L S/F) 400,000 0.69%
    P Partnership Pacific Services Pty Limited (P P Pacific Super Fund A/C) 350,000 0.60%
    Dadiaso Holdings Pty Ltd (The David Shein Inv A/C) 350,000 0.60%
    Asket Pty Ltd (S L Pynt Super Fund A/C) 316,240 0.54%
    Damon Groenveld 304,000 0.52%

    Profile

    since

    Note